Key result
Application of the illness-death model projected a 1.3% decrease in anxiety disorders among women and an 8.5% increase among men in Germany by 2030, differing from simple prevalence extrapolation.
Why the study?
Estimates of future disease burden support public health decision-making, but multistate modeling of chronic diseases remains limited.
The illness-death model with discrete time steps provides a framework for projecting chronic disease burden, yielding different estimates than simple prevalence extrapolation when applied to anxiety disorders.
Answers are grounded in this paper and cite their sources.
New discrete-time illness-death recursion enables chronic disease projections; leaves open validation and cardiovascular applications.
Introduction: Estimates of future disease burden supports public health decision-making. Multistate modeling of chronic diseases is still limited despite a long history of mathematical modeling of diseases. We introduce a discrete time approach to the illness-death model and a recursion formula, which can be utilized to project chronic disease burden. We further illustrate an example of the technique applied to anxiety disorders in Germany. Materials and Equipment: The illness-death model is a multistate model that relates prevalence, incidence, mortality, and remission. A basic recursion formula that considers prevalence, incidence, mortality among the susceptible, and mortality among the diseased can be applied to irreversible chronic diseases such as diabetes. Among several mental disorders, remission plays a key role and thus an extended recursion formula taking remission into account is derived. Methods: Using the Global Burden of Disease Study 2019 data and population projections from the Federal Statistical Office of Germany, a total number of individuals with anxiety disorders by sex in Germany from 2019 to 2030 was projected. Regression models were fitted to historical data for prevalence and incidence. Differential mortality risks were modeled based on empirical evidence. Remission was estimated from prevalence, incidence, and mortality, applying the extended recursion formula. Sex- and age-specific prevalence of 2019 was given as the initial value to estimate the total number of individuals with anxiety disorders for each year up to 2030. Projections were also made through simple extrapolation of prevalence for comparison. Results: From 2019 to 2030, we estimated a decrease of 52,114 (-1.3%) individuals with anxiety disorders among women, and an increase of 166,870 (+8.5%) cases among men, through the illness-death model approach. With prevalence extrapolation, an increase of 381,770 (+9.7%) among women and an increase of 272,446 (+13.9%) among men were estimated. Discussion: Application of the illness-death model with discrete time steps is possible for both irreversible chronic diseases and diseases with possible remissions, such as anxiety disorders. The technique provides a framework for disease burden prediction. The example provided here can form a basis for running simulations under varying transition probabilities.
No takes yet. Share an insight, caveat, or question.
Ito et al. (2022) studied Anxiety disorders. Illness-death model vs. Simple prevalence extrapolation was evaluated on Projected change in number of individuals with anxiety disorders from 2019 to 2030. Application of the illness-death model projected a 1.3% decrease in anxiety disorders among women and an 8.5% increase among men in Germany by 2030, differing from simple prevalence extrapolation.
Synapse has enriched 10 related papers. Consider them for comparative context: